StemSoft Gains ISBT 128 Vendor Certification
StemSoft Software Inc, a company dedicated to providing software solutions that meet the needs of researchers and clinicians involved in cell-based processing, manipulation, and therapies is pleased to announce that the next release of StemLab, version 3.3, will include the ability to read and generate ISBT 128 Identification Numbers and bar codes.
Article
Invitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells
Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics, and the Wisconsin Alumni Research Foundation, the private, non-profit patenting and licensing organization for the University of Wisconsin-Madison, announced recently that they have signed a license for human embryonic stem cell patents for the development of research tools.
Article
Osiris and NuVasive Enter into Definitive Agreement for Osteocel(R)
Osiris Therapeutics, Inc. recently announced that it has entered into a definitive agreement with NuVasive, Inc. to sell Osiris’ Osteocel business for up to $85 million in upfront and milestone payments.
Article
New Venture for Therapy with Cord Blood and Adult Stem Cells
Professor Colin McGuckin, Chair in regenerative medicine at Newcastle University and the Fondation Jerome Lejeune in Paris has announced the formation of a new venture ‘Novussanguis’ to promote responsible research on cord blood and adult stem cells.
Article
Stratatech Awarded $1,186,000 NIH Grant
Stratatech Corporation has received a $1,186,000 Phase II STTR Grant from the National Institute of Aging. Under this Grant, Stratatech will continue its work to develop cell-based gene therapy products for the use in the treatment of chronic skin ulcers, such as venous stasis and pressure ulcers, which are particularly problematic for the aged population.
Article
Scientists to Develop Stem Cell Therapies to Mend Livers and Bones
The research is the one of two projects at the University of Edinburgh receiving a total of £3.6 million from Scottish Enterprise, the Medical Research Council, in collaboration with the UK Stem Cell Foundation. The second, which also involves embryonic stem cells, will look at new ways to repair damaged bone and cartilage.
Article
BioLife Solutions Announces FDA Master File Acceptance for CryoStor(TM) Pre-formulated Cryopreservation Media
BioLife Solutions Inc. recently announced that its Master File for CryoStor cryopreservation media has been accepted by the United States Food and Drug Administration.
Article
Secure Medical CEO John Rao Joins Histogen Board of Directors
Histogen, Inc. has announced that John Rao, founder and CEO of Secure Medical Inc., a medical technology company, has joined Histogen’s Board of Directors.
Article
ImmuneRegen(R) Appoints Renowned Hematologist Ivan N. Rich, Ph.D. to Advisory Board
ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. has announced it has appointed Ivan N. Rich, Ph.D., to its advisory board.
Article
Neuralstem Sues StemCells, Inc. Over New Patent
Stem cell company Neuralstem, Inc. is filing suit against StemCells, Inc. stating, among other things, that StemCells intentionally withheld crucial information highly material to the patentability of StemCells’ “new” patent (US Pat No. 7,361,505) and that this was done with the intent to deceive the United States Patent Office in order to get the ‘505 patent allowed.
Article
Living Cell Technologies Prepares to List on the International OTCQCX in the USA
Living Cell Technologies Limited recently announced it has applied to list its American Depository Receipt program on the International OTCQX to increase the Companys exposure to U.S. investors.
Article